PIK3CA and glioblastoma: To further assess specificity of our NMR-detected metabolic changes to PI3K inhibition rather than anti-proliferative effects, the SF188 pediatric glioblastoma cell line was treated with PI-103 or the cytotoxic drug TMZ.